ANY IDEAS?

The China Story No One's Telling:

How a gov't-backed
"Hai Gui" could help you earn 550% in just 18 months

Made possible by the richest government on Earth, this opportunity was the subject of a recent Harvard Business School Case Study—and has helped savvy U.S. investors earn as much as $18,240 in just the past 30 days...



Dear Reader,

I'm writing to tell you about the "Hai Gui"...

Created and backed by the world's richest government (China), this unusual situation is, in my opinion, the best moneymaking opportunity in the world today.

And as Beijing resident Ying Luo says, offers "the opportunity for you to be superrich."

In fact, China's richest man, Li Ka-Shing, is already taking advantage of the situation. So are savvy Americans:
● A Californian named Brian Bilger surfaced as an early investor in the "Hai Gui" movement in February 2006, and has increased his net worth more than $42,000 as a result.
● A Minnesota man named David Benson has recently taken advantage of the "Hai Gui." Since November 1st of this year, and he's increased his earnings by $18,240.
● A Massachusetts' man named James Finch has done even better—he's worth about $172,000 more than he was just 30 days ago as a result of the "Hai Gui."

As you'll see, the Hai Gui has nothing to do with the dozen or so popular China stories you've probably read about over the past year or two.

Like most valuable pieces of financial information, this story is still completely off the radar in the mainstream press.

Our exhaustive search of more than 1,500 major media outlets found just one mention in the London-based Economist... and only a few lines in The Wall Street Journal. (But it has been the subject of a recent Harvard Business School Case Study.)

I know, it's hard to believe that there might still be a unique way to make a fortune from China, which you've never heard about before.

But this situation is real... backed by the federal and local governments... and is happening right now. Plus it's the one China opportunity that's still new--and cheap.

I know about it only because of long-standing connections with two Asian expatriates, who showed me the detailed government documents in person.

It's a complex story, no doubt. We've spent months figuring it all out... poring through government documents, and interviewing the key players. Most investors will never even know this opportunity exists.

But if you are willing to take the time to learn what's going on, there's a lot of money to be made, very quickly.

I've explained everything here in these pages...

A gov't-backed way to get rich

What is the "Hai Gui" exactly?

In short, it's a key part of China's latest government-backed economic development plan--which has created an incredible investment opportunity for regular people like you and me, right here in the United States.

Let me show you how it came about...

Ever since the 1970s, when Chairman Deng Xiaoping declared that the country's new motto would be "to get rich is glorious," China has been on a tear.

Thanks to cheap labor, a cheap currency, and government subsidies, the country has become the undisputed manufacturing center of the world...

Today China produces more than half of the world's shoes, toys, microwave ovens, digital cameras, clothing, and DVD players, just to name a few.

But now the Chinese government is ready for the next step...

As the British Broadcasting Corporation (BBC) reported earlier this year: "China does not want to make other people's products forever. It plans to start inventing products of its own."

One of the areas where the Chinese government is focusing most heavily is science.
● The Chinese government has implemented what they call the "Eleven-Five Program" (for 2006-2011) to accelerate the country's science and biotechnology industry. They want to create 10 large-scale biotech enterprises with sales exceeding $1.4 billion... and 8 biotech industry bases which produce sales exceeding $7 billion
● The government's most important funding act might be the National High Technology Research and Development Program—what's also known as Program "863." From 2001 to 2005, program 863 handed out $400 million to biotech companies... 4-times the amount given out over the previous 5-year period. Over the next five years they'll give away $1.4 billion to biotech companies.
● And the Ministry of Finance and Ministry of Science and Technology recently established a $13 billion fund to develop 15 national bioindustry bases to push development even further.

CNTD...

The safe way to make a
fortune from the Hai Gui

One of the great secrets of the scientific community (both here and in China) is the fact that almost every large biotech and pharmaceutical company in the world outsources a large percentage of their research and development (R&D).

What most people don't realize is that it's the companies that do this work (not the big pharmaceutical firms) that are the real moneymakers for individual stock owners like you and me...
● For example, a New Jersey-based drug R&D company called Covance has paid shareholders 657% gains since the beginning of 2000
●

A North Carolina drug R&D company called Pharmaceutical Product Development has paid shareholders an incredible 1,299% during the same period
● And a Massachusetts-based drug R&D company called Parexel International has paid shareholders gains of 419% since October 2002

These R&D companies are known in the industry as Contract Research Organizations, or "CROs."

In essence, CROs run sophisticated chemical tests to find promising compounds. They also do the actual drug trials with test patients, and compile the government-required data.

And herein lies our opportunity: China's savviest "Hai Gui" are now taking advantage of huge government perks to open new CROs in their home country.

These CROs are in a real sweet spot because they get all the government backing of the biotechs... without the risks of having to develop new drugs.

These companies are already making great profits, thanks to their connections with the biggest drug firms in America.

What's nice for investors is that these CROs are low-risk, high profit margin businesses... they get paid for every test they run, whether it passes or fails.

You can become an early investor, and make a lot of money over the next few years...
How to double your money every year

In China, scientist salaries are up to 80% less than the Western world.

Similarly, the construction of roads, buildings, and equipment in China costs less than HALF of what it does in the United States.

On top of that, because the Chinese government wants these CRO businesses to succeed, they are offering huge incentives in the form of tax breaks (some of these companies are exempted down to almost ZERO taxes), discounted real estate and construction costs, and cheap electricity and water.

What it boils down to is this: Chinese CROs can cut overall drug development costs by 30% or more.

And since the average drug costs about $800 million to develop and bring to market in the U.S., that translates to hundreds of millions in savings for big drug companies... and millions in profits for the best CROs:
● One new China CRO, for example, increased its net profits 452% last year, over the year before. Another CRO increased its net profits 102% during the same period.
●

One Chinese CRO has been ranked in the Top-50 "Fastest Growing Businesses in China" for three years in a row... and was even the subject of a Harvard Business School study.
● Another Chinese CRO, which does research for AstraZeneca and Johnson & Johnson, won the international consulting firm Frost & Sullivan's "Asian Growth Strategy of the Year" Award last year.
● These companies have already signed huge, multi-million dollar contracts with more than 70 of the biggest and most profitable biotech and pharmaceutical companies around the world: Pfizer, Merck, AstraZeneca, Eli Lilly, Johnson & Johnson, Bayer, Novartis, Roche, GlaxoSmithKline... and dozens more.

Despite these developments, China's CROs—including international ones—still only "represent a tiny sliver" of the overall market, according Michael Rosen, a senior vice president of The Science & Technology Group at Forest City Enterprises.

The point is, these are among the newest and fastest-growing high-tech companies in the world... with lots of room to grow.

And with the backing and incentives of the Chinese government, they can make investors an absolute fortune.

These companies will dominate this industry for years and years to come—but right now, not 1 in 1,000 investors has heard of them.

That's why we believe you have a rare opportunity to make as much as 10-times your money over the next few years.

Some of these Chinese CROs are publicly traded in Hong Kong and Japan. Others are listed (and are even headquartered) right here in the United States. Many of them have gone public in the past few years... and two have even gone public in just the past six months.

Honzjajs / WWP

The cautionary comments from WWP source are pretty accurate, I have had the dubious pleasure of visiting quite a few CRO's and Chinese pharma manufacturing facilities, as part of my job. While some are certainly better than others, they philosophy is same, cost above all else. Consumer safety is often a secondary or even tertiary consideration. In my opinion, a lot of these Chinese drug companies are an accident waiting to happen, and with the West protectionist tendencies politically, a major incident with any of these, will hugely impact all others ability to sell into the more lucrative markets. Chinese Pharma investments.. handle with care for another 5 -10 years.....

Good snooping, fanball -- that's definitely one I've never run across before. Of course, obscure doesn't mean good, though I suppose some folks might feel better about shelling out $5,000 for a newsletter if they recommend difficult-to-trade stocks most people have never heard of. That's certainly a big part of the business plan of some of these newsletters (not necessarily this particular one): find something obscure first that lends itself to a good sales pitch, then worry about whether it's any good.

This one was not easy but its right in front of our faces..... It was commented on Stansberry last week to on DJ news service but its.................................................................................WX anyone else have a comment Thx